Amide containing NBTI antibacterials with reduced hERG inhibition, retained antimicrobial activity against gram-positive bacteria and in vivo efficacy

Autor: Maja Kokot, Matjaž Weiss, Irena Zdovc, Lidija Senerovic, Natasa Radakovic, Marko Anderluh, Nikola Minovski, Martina Hrast
Jazyk: angličtina
Rok vydání: 2023
Předmět:
Zdroj: European journal of medicinal chemistry, str. 1-13 : Ilustr., Vol. 250, 2023
COBISS-ID: 25429760
European journal of medicinal chemistry, vol. 115160, no. 250, pp. 1-13, 2023.
ISSN: 0223-5234
Popis: Novel bacterial topoisomerase inhibitors (NBTIs) are new promising antimicrobials for the treatment of multidrug-resistant bacterial infections. In recent years, many new NBTIs have been discovered, however most of them struggle with the same issue - the balance between antibacterial activity and hERG-related toxicity. We started a new campaign by optimizing the previous series of NBTIs, followed by the design and synthesis of a new, amide-containing focused NBTI library to reduce hERG inhibition and maintain antibacterial activity against Gram-positive bacteria, including methicillin-resistant Staphylococcus aureus (MRSA). This optimization strategy yielded the lead compound 12 that exhibits potent antibacterial activity against Gram-positive bacteria, reduced hERG inhibition, no cardiotoxicity in zebrafish model, and a favorable in vivo efficacy in a neutropenic murine thigh infection model of MRSA infection. Št. članka: 115160. Bibliografija: str. 12-13. Abstract. ARRS ARRS Young researcher’s program Young researcher’s program
Databáze: OpenAIRE